Increase in brain tumors is not attributed to mobile phone use
the ONA take:
New research from the University of Auckland found that risk of brain cancer is not increased by mobile phone use. Concerns have been raised about whether use of mobile phones can increase the incidence of brain cancers.
Previous studies from around the world reported findings that showed no risk or a slightly increased risk, with some studies suggesting a substantial risk.
The New Zealand team examined the frequency of brain cancers in total and in subtypes highlighted in other studies, using data from the New Zealand cancer registry.
These investigators found no general increase. They did see, however, was a decrease of approximately 1% per year in people 10 to 69 years. Based on their findings, they report previous findings of large increases in risk are likely to be incorrect.
However, they concede that a study of this type cannot exclude a small risk, or one limited to certain subtypes of cancers, or a risk arising after more than 15 years of phone use.
The research team cannot explain the decrease in brain cancers in New Zealand. An increase in some types of brain cancer among people 70 years and older—in New Zealand and other countries—may be related to improved diagnosis.
Brain cancer is not increased by mobile phone use.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|